Table 1.
Studies of Antibiotic Dosage Analysis in SLED.
| Study | Drug | Dose | No. of subjects | Dialysis machine | SLED characteristics | Pharmacokinetics in SLED | Recommendations |
|---|---|---|---|---|---|---|---|
| Ahern et al7 | Vancomycin | Single dose 15 mg/kg IV | 11 | Fresenius 2008 H (Fresenius medical care) | Dialysate flow rate100 mL/min and blood flow rate 200 mL/min. Dialysis duration 24 h | Mean half-life 43.1 hr and mean clearance 24.3 mL/min. Mean volume of distribution 0.84 L/kg. Mean volume of distribution 0.84 ± 0.17 L/kg | Initial dose of 15 mg/Kg and measurement of serum drug levels at 24 h |
| Kielstein et al8a | Vancomycin | Single dose 1 g IV 12 h prior to dialysis | 10 | Batch dialysis system (GENIUS, Fresenius Medical care, Bad Homburg) with polysulfone high-flux dialyzer with surface area 1.3 m2 | Both dialysate and blood flow rate 160 mL/min. Dialysis duration 480 ± 6 min | Mean half-life 11.2 h. Mean clearance 2.1 L/h and 3.8 L/h based on analysis method. Mean volume of distribution 0.57 L/kg | Initial dose of 20-25 mg/kg and monitoring of drug levels for further dosing. |
| Manley et al9 | Gentamicin* | Single dose of 0.6 mg/kg IV post dialysis | 8 | Fresenius Medical care, high-flux polysulfone F50 filter with surface are 0.5 m2 | Blood flow rate 200 mL/min and dialysate flow rate 300 mL/min. Duration of dialysis 480 min | Mean half-life 3.7 ± 0.8 h. Mean clearance 75.9 ± 38.4 mL/min/1.73 m2. Mean volume of distribution 0.28 L/kg | 2-2.5 mg/kg after hemodialysis to maintain optimal peak and trough levels at 7.5 µg/mL and 0.8 µg/mL, respectively |
| Kielstein et al8a | Meropenem | Single dose 1 g IV 6 h prior to dialysis | 10 | Batch dialysis system (GENIUS, Fresenius Medical care, Bad Homburg) with polysulfone high-flux dialyzer with surface area 1.3 m2 | Both dialysate and blood flow rate 160 mL/min. Dialysis duration 480 ± 6 min | Mean half-life 3.7 h. Mean clearances 2.3 and 5.1 L/h based on analysis method. Mean volume of distribution 0.72 L/kg | 0.5-1 g every 8 h |
| Braune et al10 | Meropenem | Varying doses of 0.5 g, 1 g and 2 g IV over 30 min every 8 h | 19 | GENIUS batch system (Fresenius Medical Care, Bad Homburg, Germany) with Fresenius FX 60 filter (surface area 1.4 m2) | Mean SLED duration 315 min. Mean blood/dialysate flow rate 250 mL/min and ultrafiltration rate 500 mL/h. | The PTA for 40% fT >MIC and 100% fT >MIC was >95% with a meropenem dose of 0.5 g 8 hourly for Pseudomonas aeruginosa (MIC ⩽2) in patients without residual diuresis, whereas it was >95% and 93% with a dose of 1 g 12 hourly and 2 g 8 hourly, respectively, in patients with 300 mL/d residual diuresis. In patients with residual diuresis, FTA of 97% was achieved with a dose of 2 g 8 hourly for 100% fT >MIC | Pharmacokinetic properties are significantly influenced by the degree of residual diuresis in patients undergoing SLED. Therapeutic drug monitoring may help optimize individual dosing |
| Burkhardt et al11 | Ertapenem | Single dose of 1 g IV | 6 | Batch dialysis system (GENIUS, Fresenius Medical care, Bad Homburg) with polysulfone high-flux dialyzer with surface area 1.3 m2 | Mean blood and dialysate flow 160 mL/min. Dialysis duration 480 min | Half-life 6.7 h. Mean clearance 49.5 ± 10.9 mL/min. Volume of distribution 15.9 ± 3.2 L | 1 g/d |
| Fiaccadori et al12 | Linezolid | Single dose of 600 mg IV before dialysis | 15 | Fresenius Medical Care (low-flux polysulfone filters with 1.6 m2 surface area) | Blood flow 200 mL/min and dialysate flow 100 mL/min. Dialysis duration 8-9 h | Half-life 5.88 h and clearance 33.3 mL/min. Volume of distribution 30.19 L | Drug should be administered toward the end of dialysis session |
| Czock et al13b | Moxifloxacin | Single dose of 400 mg IV 8 h prior to dialysis | 10 | GENIUS batch system (Fresenius Medical Care, Bad homburg) with polysulfone high-flux dialyzer with surface area 1.3 m2 | Mean blood and dialysate flow 161 ± 4 mL/min. Dialysis duration 481 ± 9 min | Mean half-life 6 h and mean clearances 2 L/h and 3.1 L/h based on analysis method. Mean volume of distribution 3.8 L/kg | Standard 400 mg/d irrespective of liver impairment |
| Czock et al13b | Levofloxacin | Single dose of 250/500 mg IV 12 h prior to dialysis | 5 | GENIUS batch system (Fresenius Medical Care, Bad homburg) with polysulfone high-flux dialyzer with surface area 1.3 m2 | Mean blood and dialysate flow 161 ± 4 mL/min. Dialysis duration 481 ± 9 min | Mean half-life 10.3 h and mean clearances 2.93 L/h and 3.12 L/h based on analysis method. Mean volume of distribution 1.71 L/kg | Dosage adjustment is necessary and drug should be given after dialysis |
| Lorenzen et al14 | Ampicillin/sulbactam | Single dose of 2 g/1 g IV 3 h prior to dialysis | |||||
| Multiple doses of 2 g/1 g twice daily for 4 days | 12 | GENIUS batch system (Fresenius Medical Care, Bad homburg) with polysulfone high-flux dialyzer with surface area 1.3 m2 | Mean blood and dialysate flow 162 ± 6 mL/min. Dialysis duration 442 ± 77 min | Mean volume of distribution for ampicillin/sulbactam were 13.1 ± 11.1 L and 22 ± 21.8 L, respectively, mean half-life 2.8 ± 0.8 h and 3.5 ± 1.5 h, respectively, mean clearances 80.1 ± 7.7 mL/min and 83.3 ± 12.1 mL/min, respectively | |||
| No significant drug toxicity with twice daily dosing | Twice daily dosing 2 g/1 g with one dose given after dialysis | ||||||
| Clajus et al15 | Trimethoprim/sulfamethoxazole | 15 mg/kg/d and 95 mg/kg/d IV | 1 | GENIUS batch system (Fresenius Medical Care, Bad homburg) with polysulfone high-flux dialyzer with surface area 1.3 m2 | Mean blood and dialysate flow 170 ± 41 mL/min. Dialysis duration 442 ± 101 min | Clearances 94 ± 20.2 mL/min and 51 ± 18.8 mL/min, respectively | Further studies needed to establish dosing recommendations |
| Strunk et al16 | Colistin | 6 million units loading dose and 3 million units every 8 h | 1 | High flux 1.3 m2 dialyzer | Mean blood and dialysate flow rate 191 mL/min and 121 mL/min, respectively. Average dialysis duration 552 min | Colistin clearance 54-71 mL/min and colistin methanesulfonate 25-62 mL/min | Recommends loading dose of 6 million units and maintenance of 3 million units every 8 h |
| Konig et al17 | Ceftazidime | 1-2 g IV over 30 min 8-12 hourly | 16 | Genius batch system (Fresenius Medical Care, Bad Homburg, Germany) with Fresenius FX 60 filter (surface area 1.4 m2) | Mean duration of SLED 299 min. Mean blood/dialysate flow rate 264 mL/min and mean ultrafiltration 540 mL/h | Mean clearance on SLED was 5.32 L/h versus 1.06 L/h off SLED. PTA for 50% fT >MIC was 98% at a dose of 1g IV 8 hourly. | Ceftazidime at a dose of 1g IV 8 hourly and 2g IV 12 hourly is adequate for attaining 50% fT >MIC and 100% fT>MIC, respectively, for susceptible pathogens (MIC ⩽8mg/L) |
Note. SLED = sustained low-efficiency dialysis; kg = kilogram; IV = intravenous; PTA = probability of the target attainment; fT >MIC = blood levels of the given drug to be more than minimum inhibitory concentration for a specified duration of the dosing interval; FTA = fractional target attainment.
Denotes single study but 2 different antibiotics.
Denotes single study but 2 different antibiotics.
Slow daily home dialysis